Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:April 17, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:April 17, 2018Completed
Condition(s):Renal Cell CarcinomaLast Updated:December 23, 2021Completed
Condition(s):Renal Cell CarcinomaLast Updated:April 26, 2018Terminated
Condition(s):Renal Cell CancerLast Updated:April 29, 2009Unknown status
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:March 5, 2015Unknown status
Condition(s):Carcinoma, Renal CellLast Updated:May 13, 2013Completed
Condition(s):Renal Cell CarcinomaLast Updated:February 8, 2017Terminated
Condition(s):Carcinoma, Renal Cell; Clear-cell Metastatic Renal Cell CarcinomaLast Updated:October 6, 2022Completed
Condition(s):Renal Cell Carcinoma; Metastatic Renal Cell CarcinomaLast Updated:April 11, 2023Terminated
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:February 25, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.